Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph phase_2
2
50%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting2
Enrolling by invitation2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 32 (50.0%)

Trials by Status

recruiting250%
enrolling_by_invitation250%

Recent Activity

2 active trials
Showing 4 of 4
enrolling_by_invitationphase_3

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

NCT06194799
enrolling_by_invitationphase_3

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

NCT07095465
recruitingphase_2

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

NCT07029581
recruitingphase_2

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673

Clinical Trials (4)

Showing 4 of 4 trials
NCT06194799Phase 3

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Enrolling By Invitation
NCT07095465Phase 3

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

Enrolling By Invitation
NCT07029581Phase 2

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Recruiting
NCT06159673Phase 2

ACP-204 in Adults With Alzheimer's Disease Psychosis

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4